DM
AQST icon

Deerfield Management’s Aquestive Therapeutics AQST Stock Holding History

Deerfield Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-155,145
Closed -$773K – 136
2024
Q3 		$773K Buy
155,145
+8,990
+6% +$35K 0.01% 199
2024
Q2 		$380K Buy
+146,155
New +$488K 0.01% 308

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Deerfield Management's AQST Position: Q4 2024 in Review

Deerfield Management sold out of Aquestive Therapeutics (AQST) in Q4 2024, closing a stake of 155,145 shares — an estimated $773K sold.

Deerfield Management first reported a position in AQST in Q2 2024 and held it in 2 quarters. The position peaked at $773K in Q3 2024. 114 funds tracked by Wall St. Rank hold AQST as of Q4 2024.

  • Deerfield Management reported no remaining Aquestive Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Deerfield Management sold 155,145 Aquestive Therapeutics shares in Q4 2024, an estimated $773K.
  • Deerfield Management first reported a position in Aquestive Therapeutics in Q2 2024 and held it in 2 quarters.
  • Deerfield Management's Aquestive Therapeutics position peaked at $773K in Q3 2024.
  • 114 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q4 2024.

Based on Deerfield Management's 13F filing for Q4 2024, filed 14 Feb 2025.